Cognitive Training + tDCS for Depression

SM
SM
Overseen BySarah M Szymkowicz, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Vanderbilt University Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether a gentle brain stimulation technique, transcranial direct current stimulation (tDCS), can enhance the effects of brain exercises on depression in older adults. It targets individuals who have experienced depression at least twice, with one episode occurring in the last three years. Participants may receive either real or sham brain stimulation during cognitive training sessions. This trial suits those over 60 who have had depression and face memory or thinking challenges in daily life. As an unphased trial, it provides an opportunity to contribute to innovative research that could improve depression treatments for older adults.

Will I have to stop taking my current medications?

The trial requires that participants either have a stable antidepressant regimen for at least 6 weeks or not be on any current antidepressant treatment. However, you cannot participate if you are taking medications that significantly interact with tDCS, like sodium channel blockers or anticonvulsants.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that transcranial direct current stimulation (tDCS) combined with cognitive training is safe for individuals with various mental health conditions. Studies have found that this combination enhances thinking skills and is generally well-tolerated.

For example, one study found that a 10-week tDCS treatment for major depression was both effective and safe, with participants reporting high satisfaction. Another study demonstrated that this method did not cause any major side effects and remained safe even when conducted remotely.

Overall, existing research suggests that tDCS with cognitive training is safe for individuals.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about these treatments for depression because they combine cognitive training with transcranial direct current stimulation (tDCS), offering a potentially new way to enhance brain function. Unlike traditional antidepressants, which often target chemical imbalances, this approach may help in rewiring brain networks through non-invasive electrical stimulation. The study features two arms: one uses active tDCS, which could directly influence brain activity, and the other uses sham stimulation to help determine the effectiveness of the active approach. This combination could offer a novel, non-pharmaceutical option for those who haven't responded well to existing therapies.

What evidence suggests that this trial's treatments could be effective for depression?

In this trial, participants will be divided into two groups. One group will receive Cognitive Training combined with active transcranial direct current stimulation (tDCS). A previous study showed that combining brain exercises with active tDCS improved mental skills like attention and processing speed. Another study found that a 10-week course of active tDCS significantly reduced symptoms of depression. These findings suggest that adding active tDCS to brain exercises might enhance its effectiveness in treating depression. However, the improvements observed in these studies were small, so participants should maintain realistic expectations.

The other group will receive Cognitive Training combined with sham tDCS. For this group, the benefits primarily come from the brain exercises alone, which have been shown to improve mental skills.12356

Who Is on the Research Team?

SM

Sarah M Szymkowicz, PhD

Principal Investigator

Vanderbilt University Medical Center

Are You a Good Fit for This Trial?

This trial is for adults aged 60 and over who have been diagnosed with Major Depressive Disorder, as per DSM-5 criteria. They should be experiencing cognitive complaints and a depression severity of 15+ on the MADRS scale. Participants must speak English fluently and either be on a stable antidepressant regimen for at least six weeks or not taking any antidepressants.

Inclusion Criteria

You have reported problems with memory and thinking on a specific questionnaire.
My depression is severe, scoring 15 or more on a scale.
I have been on the same antidepressant for at least 6 weeks or am not taking any.
See 3 more

Exclusion Criteria

You have a significant memory problem compared to other people your age, even though your overall thinking skills seem normal.
I have a neurological disorder such as dementia, stroke, or Parkinson's.
Current involvement in other research studies (including but not limited to: neuromodulation [TMS or tDCS] or investigational drug studies)
See 9 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either active or sham tDCS combined with daily computerized cognitive remediation over 4 weeks

4 weeks
Daily visits for treatment

Follow-up

Participants are monitored for cognitive and psychiatric outcomes post-intervention

3 months
Cognitive assessments at 3 months post-intervention

What Are the Treatments Tested in This Trial?

Interventions

  • Cognitive Training
  • tDCS (active stimulation)
  • tDCS (sham stimulation)
Trial Overview The study examines if transcranial direct current stimulation (tDCS), which uses mild electrical currents applied to the head, can improve cognitive function when combined with cognitive training in older adults suffering from depression.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Cognitive Training + Sham StimulationExperimental Treatment2 Interventions
Group II: Cognitive Training + Active StimulationExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vanderbilt University Medical Center

Lead Sponsor

Trials
922
Recruited
939,000+

American Academy of Neurology

Collaborator

Trials
12
Recruited
370+

Published Research Related to This Trial

A home-based protocol for transcranial direct current stimulation (tDCS) was tested on 26 participants with major depressive disorder (MDD) over 6 weeks, showing significant improvement in depressive symptoms that persisted for at least 6 months.
The treatment was highly acceptable to participants, with 92.3% completing the study, indicating that tDCS could be a feasible and effective option for managing MDD outside of clinical settings.
Adjunctive home-based transcranial direct current stimulation treatment for major depression with real-time remote supervision: An open-label, single-arm feasibility study with long term outcomes.Woodham, RD., Rimmer, RM., Young, AH., et al.[2022]
Transcranial direct current stimulation (tDCS) shows potential for reducing symptoms of major depression, particularly when applied to frontal brain regions, but results have been inconsistent across studies.
Currently, no tDCS devices are FDA-cleared for clinical use, and while older systems have some regulatory approval, they lack demonstrated efficacy in rigorous trials, highlighting the need for more research and education in this area.
Transcranial Direct Current Stimulation in Psychiatry: What Psychiatrists Need to Know.Zandvakili, A., Berlow, YA., Carpenter, LL., et al.[2020]
In a study involving 75 severely depressed psychiatric inpatients, metacognitive training for depression (D-MCT) did not show a significant added benefit over standard cognitive-behavioral therapy (CBT) in reducing overall depression severity, but it was particularly effective for patients with major depressive disorder (MDD) without comorbidities, leading to greater improvements in depressive cognition.
Patients reported higher satisfaction, motivation, and treatment preference for D-MCT, indicating it is a well-accepted and feasible intervention in acute psychiatric care, although further research is needed to assess its long-term effects.
Efficacy of metacognitive training for depression as add-on intervention for patients with depression in acute intensive psychiatric inpatient care: A randomized controlled trial.Hauschildt, M., Arlt, S., Moritz, S., et al.[2022]

Citations

Combined Cognitive Training and Transcranial Direct Current ...Retained studies included cognitive training combined with active or sham tDCS in a neuropsychiatric population and reported a post-treatment cognitive outcome.
A randomized, double-blind, sham-controlled trialIn a doubleblind, sham-controlled trial, tDCS+CT improved inhibitory control, processing speed, and divided attention, although the effects were small. •.
Cognitive Training and Transcranial Direct Current ...Participants with PD-MCI receiving cognitive training (standard or tailored) or tDCS demonstrated significant improvements on cognitive and functional outcomes, ...
Efficacy of Augmentation of Cognitive Behavioral Therapy ...In this randomized clinical trial including 148 patients, a 6-week CBT group intervention augmented by tDCS was not found to be superior to CBT plus sham-tDCS ...
Home-based transcranial direct current stimulation ...In summary, a 10-week course of home-based active tDCS was associated with greater improvements in depressive symptoms, clinical response and ...
Effect of combined transcranial direct current stimulation ...Our results demonstrated that cognitive training led to significantly improved overall white matter integrity, with no additional benefits ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security